- Home
- DRUG vs ANPA Comparison
DRUG vs ANPA Comparison
Compare DRUG & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- ANPA
- Stock Information
- Founded
- DRUG 2019
- ANPA 2016
- Country
- DRUG United States
- ANPA Hong Kong
- Employees
- DRUG N/A
- ANPA N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- ANPA
- Sector
- DRUG Health Care
- ANPA
- Exchange
- DRUG Nasdaq
- ANPA Nasdaq
- Market Cap
- DRUG 364.8M
- ANPA 300.0M
- IPO Year
- DRUG N/A
- ANPA 2025
- Fundamental
- Price
- DRUG $56.97
- ANPA $33.42
- Analyst Decision
- DRUG Strong Buy
- ANPA
- Analyst Count
- DRUG 9
- ANPA 0
- Target Price
- DRUG $81.67
- ANPA N/A
- AVG Volume (30 Days)
- DRUG 190.6K
- ANPA 6.8K
- Earning Date
- DRUG 12-30-2025
- ANPA 09-30-2025
- Dividend Yield
- DRUG N/A
- ANPA N/A
- EPS Growth
- DRUG N/A
- ANPA N/A
- EPS
- DRUG N/A
- ANPA 0.06
- Revenue
- DRUG N/A
- ANPA $5,832,684.00
- Revenue This Year
- DRUG N/A
- ANPA N/A
- Revenue Next Year
- DRUG N/A
- ANPA N/A
- P/E Ratio
- DRUG N/A
- ANPA $540.24
- Revenue Growth
- DRUG N/A
- ANPA N/A
- 52 Week Low
- DRUG $23.18
- ANPA $2.80
- 52 Week High
- DRUG $70.23
- ANPA $54.75
- Technical
- Relative Strength Index (RSI)
- DRUG 49.89
- ANPA N/A
- Support Level
- DRUG $55.01
- ANPA N/A
- Resistance Level
- DRUG $61.81
- ANPA N/A
- Average True Range (ATR)
- DRUG 3.80
- ANPA 0.00
- MACD
- DRUG -0.06
- ANPA 0.00
- Stochastic Oscillator
- DRUG 61.06
- ANPA 0.00
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About ANPA Rich Sparkle Holdings Limited Ordinary Shares
Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.